CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhIL-15) is associated with expansion of peripheral blood CD56+ NK cells and CD8+ T cells. Issue 2 (December 2015) - Morishima, Chihiro; McNeel, Douglas; Patel, Manish; Kohrt, Holbrook; Waldmann, Thomas; Thompson, John; Conlon, Kevin; Sondel, Paul; Wakelee, Heather; Apodaca, Minjun; Fling, Steven; Disis, Mary; et al.